Financial

Humanitarian and Philanthropic Leader Vivian G. Bass Elected President of Save a Child’s Heart

ROCKVILLE, Md., Jan. 11, 2022 /PRNewswire/ — Save a Child’s Heart (SACH) Board of Directors of the US branch elected Vivian G. Bass of Bethesda, Maryland to serve as President effective January 1, 2022. “Vivian is an outstanding visionary and legendary leader who is highly respected and admired by individuals of all ages, cultures, religions, and socioeconomic statuses,” […]

Eko Chief Medical Officer, Dr. Adam Saltman, Accepted into Forbes Technology Council

Forbes Technology Council, Invitation-Only Community for World-Class Technology Executives, Welcomes Dr. Saltman of Eko OAKLAND, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, announced today that the company’s chief medical officer, Adam Saltman M.D., Ph.D., has joined the Forbes Technology Council, an invitation-only community for world-class CIOs, […]

iRhythm Technologies Comments on Medicare Administrative Contractor 2022 Rate Update

SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, commented on ​​the recent update by Novitas Solutions (Novitas), a Medicare Administrative Contractor (MAC), regarding updated rates applicable to the Current Procedural Terminology (CPT) codes 93243 and […]

H-CYTE Enters Into Letter of Intent for Acquisition of Catheter Precision, Inc.

Targets one of Healthcare’s Largest Multi-Billion Dollar Markets: Cardiac Electrophysiology TAMPA, Fla., Jan. 11, 2022 (GLOBE NEWSWIRE) — H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, today announced that it has entered into a letter of intent for the acquisition of Catheter Precision, Inc. Catheter Precision is a medical device […]

Esperion Provides Preliminary Fourth Quarter 2021 Financial Results and CLEAR Outcomes Program Update

– Unprecedented CLEAR Outcomes Trial Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 85% MACE Accumulation in December – – Fourth-quarter 2021 U.S. Net Product Revenue Estimated Between $12.0 to $12.5 Million – – Company Reiterates Full-Year 2022 Operating Expense Guidance of $220 to […]

Amarin Provides Preliminary 2021 Revenue and Outlook for 2022

DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today provided a business update, including preliminary unaudited full-year 2021 revenue results. Amarin plans to discuss these results and expectations with investors in connection with the 40th Annual J.P. Morgan Healthcare Conference at which Amarin is […]

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results

MINNEAPOLIS, Jan. 10, 2022 (GLOBE NEWSWIRE) — CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced certain preliminary unaudited fourth quarter and full year 2021 revenue results, and provided a 2022 business outlook. Fourth Quarter […]